Cancers | Free Full-Text | Dendritic Cells: Behind the Scenes of T-Cell Infiltration into the Tumor Microenvironment
TNC and Fsp1 expression in BVI (A, B) Representative images of BVI in... | Download Scientific Diagram
IJMS | Free Full-Text | Extracellular Vesicles Released from Cancer Cells Promote Tumorigenesis by Inducing Epithelial to Mesenchymal Transition via β-Catenin Signaling
BST-2: at the crossroads of viral pathogenesis and oncogenesis | Future Virology
MiR-302b Suppresses Tumor Metastasis by Targeting Frizzled 6 in OSCC - S. Sun, J. Wang, J. Liu, F. Yin, C. Xin, X. Zeng, J. Li, Q. Chen, 2021
Metastasis Markers in Bladder Cancer: A Review of the Literature and Clinical Considerations - ScienceDirect
Impact of immunohistochemistry-based subtyping of GATA3, CK20, CK5/6, and CK14 expression on survival after radical cystectomy for muscle-invasive bladder cancer | Scientific Reports
BST-2 promotes survival in circulation and pulmonary metastatic seeding of breast cancer cells | Scientific Reports
Biosensor-based assay of exosome biomarker for early diagnosis of cancer
Exosomes as a new frontier of cancer liquid biopsy | Molecular Cancer | Full Text
CD317 Signature in Head and Neck Cancer Indicates Poor Prognosis - L.-L. Yang, L. Wu, G.-T. Yu, W.-F. Zhang, B. Liu, Z.-J. Sun, 2018
Cells | Free Full-Text | Human Plasmacytoid Dendritic Cells and Cutaneous Melanoma
Distinguishing primary adenocarcinoma of the urinary bladder from secondary involvement by colorectal adenocarcinoma: extended immunohistochemical profiles emphasizing novel markers | Modern Pathology
Tumor microenvironment-related dendritic cell deficiency: a target to enhance tumor immunotherapy - ScienceDirect
US20210155602A1 - Tetrahydroquinolino derivatives for the treatment of metastatic and chemoresistant cancers - Google Patents
In vivo expression profile of the antiviral restriction factor and tumor-targeting antigen CD317/BST-2/HM1.24/tetherin in humans | PNAS
Exosomes as a new frontier of cancer liquid biopsy | Molecular Cancer | Full Text
Novel therapies in urothelial carcinoma: a biomarker-driven approach - Annals of Oncology
Overexpression of the transmembrane protein BST-2 induces Akt and Erk phosphorylation in bladder cancer
Loss of the Urothelial Differentiation Marker FOXA1 Is Associated with High Grade, Late Stage Bladder Cancer and Increased Tumor Proliferation | PLOS ONE
Future directions and management of liquid biopsy in non-small cell lung cancer
In vivo expression profile of the antiviral restriction factor and tumor-targeting antigen CD317/BST-2/HM1.24/tetherin in humans | PNAS
Isolation and Detection Technologies of Extracellular Vesicles and Application on Cancer Diagnostic
